Australia TGA
Material regulatory developments from Therapeutic Goods Administration are tracked daily by Cresthaven Analytics. Over the last 90 days, 20 material briefs relevant to professionals operating in the healthcare & life sciences sector have been published below. Each brief is sourced directly from the primary regulatory feed, summarized for institutional readers, and scored for materiality.
Recent material activity
A selection of recent published briefs; this is not a complete archive.
TGA issues two infringement notices totalling $39,600 to NSW vaping goods supplier Suryam Energy
Australia's Therapeutic Goods Administration (TGA) issued two infringement notices totalling $39,600 to New South Wales-based Suryam Energy Pty Ltd on 17 September 2026, alleging unlawful supply of vaping goods under the…
Read the full Australia TGA brief →TGA publishes September 2026 licensing decisions for Australian therapeutic goods manufacturers
The Therapeutic Goods Administration (TGA) updated its register of licensing decisions for Australian manufacturers on September 15, 2026. The update reflects recent approvals, variations, and suspensions applied to indi…
Read the full Australia TGA brief →TGA opens public consultation on proposed Poisons Standard amendments covering nitrous oxide scheduling
Australia's Therapeutic Goods Administration (TGA) opened public consultation on September 10, 2026, seeking submissions on proposed amendments to the Poisons Standard for nitrous oxide. The proposals will be considered …
Read the full Australia TGA brief →TGA publishes August 2026 batch of safety-related Product Information updates for health professionals
Australia's Therapeutic Goods Administration (TGA) published its August 2026 compilation of safety-related Product Information updates on September 11, 2026. The release consolidates approved label amendments across mult…
Read the full Australia TGA brief →TGA proposes additional controls for sunscreen ingredient 4-methylbenzylidene camphor following regulatory review
Australia's Therapeutic Goods Administration (TGA) opened a public consultation on 8 September 2026 on proposed additional controls for 4-methylbenzylidene camphor (4-MBC), a UV-filter ingredient used in some Australian …
Read the full Australia TGA brief →TGA opens public consultation on proposed Poisons Standard amendments for sunscreen UV filter 4-MBC
Australia's Therapeutic Goods Administration (TGA) opened a public consultation on September 10, 2026, on proposed amendments to the Poisons Standard for 4-methylbenzylidene camphor (4-MBC), a UV filter used in sunscreen…
Read the full Australia TGA brief →TGA opens public consultation on proposed Poisons Standard amendments ahead of November 2026 ACCS meeting
Australia's Therapeutic Goods Administration (TGA) published a public consultation on September 11, 2026, inviting submissions on proposed amendments to the Poisons Standard. The proposals will be considered at the Novem…
Read the full Australia TGA brief →TGA updates classification rules for non-invasive combination products used to maintain or flush medical device lumens
Australia's Therapeutic Goods Administration (TGA) revised its classification rules on September 8, 2026 for non-invasive medical devices used to maintain patency or flush the lumen of another medical device. The revisio…
Read the full Australia TGA brief →Australia's TGA amends Clinical Decision Support System exemption criteria effective 1 November 2026
Australia's Therapeutic Goods Administration (TGA) amended the Clinical Decision Support System (CDSS) exemption on 8 September 2026, clarifying the conditions under which software qualifies for exemption from medical de…
Read the full Australia TGA brief →TGA issues $71,280 in infringement notices to importer and pharmacists over unlawful melatonin importation
On August 19, 2026, the Therapeutic Goods Administration issued 10 infringement notices totalling $71,280 to Gezond Pty Ltd and three registered pharmacists. The notices concern alleged unlawful importation of melatonin,…
Read the full Australia TGA brief →TGA and NSW Police Force execute coordinated enforcement action against illicit vaping and nicotine product distribution network in Sydney
The TGA, working with the NSW Police Force and other state and Commonwealth agencies, conducted enforcement operations on August 19, 2026 against a company allegedly importing, storing, and distributing illicit vaping go…
Read the full Australia TGA brief →TGA opens additional public consultation on Poisons Standard amendments for three industrial chemical contaminants
On August 18, 2026, the Therapeutic Goods Administration published an additional public consultation proposing amendments to the Poisons Standard for ethylene oxide, propylene oxide, and epichlorohydrin in end-use produc…
Read the full Australia TGA brief →TGA consults on automated decision-making framework for listed medicine change applications
Australia's Therapeutic Goods Administration released a consultation on August 18, 2026 proposing changes to support automated decision-making for applications to change listed medicines. This signals a structural shift …
Read the full Australia TGA brief →TGA and NSW Police seize over $120,000 in illicit peptides and anabolic steroids from influencer-linked premises
The Therapeutic Goods Administration, assisted by NSW Police, seized illicit peptide and anabolic steroid products worth over $120,000 from two residential premises in New South Wales. The operation targets products alle…
Read the full Australia TGA brief →TGA consults on expanded public disclosure framework for medical device safety, quality, and performance data
The Therapeutic Goods Administration released a consultation on August 12, 2026 proposing expanded information sharing about medical device safety, quality, and performance. The proposal invites stakeholder feedback and …
Read the full Australia TGA brief →Australia TGA release pending Cresthaven Analytics full analysis: Consultation on improving the sharing of information about medical devices
Australia TGA published a regulatory release titled 'Consultation on improving the sharing of information about medical devices'. Cresthaven Analytics' full intelligence brief is pending re-analysis; see the source link …
Read the full Australia TGA brief →TGA consults on expanded public disclosure framework for medical device safety, quality, and performance data
Australia's Therapeutic Goods Administration released a consultation on August 12, 2026 proposing expanded information sharing about medical device safety, quality, and performance. The proposal signals a structural shif…
Read the full Australia TGA brief →TGA issues public safety communication addressing defibrillator device concerns in ambulance and healthcare settings
The Therapeutic Goods Administration (TGA) issued a media release on August 12, 2026 acknowledging reported safety concerns about defibrillator devices used in ambulance services and healthcare facilities. The agency pos…
Read the full Australia TGA brief →Australia TGA release pending Cresthaven Analytics full analysis: Product Information safety updates
Australia TGA published a regulatory release titled 'Product Information safety updates'. Cresthaven Analytics' full intelligence brief is pending re-analysis; see the source link below for the complete primary text.
Read the full Australia TGA brief →TGA commences Federal Court proceedings against two medicinal cannabis companies and their director for alleged unlawful advertising
On August 4, 2026, the Therapeutic Goods Administration filed Federal Court proceedings against Better Leaf Pty Ltd, Better Life Aussie Pty Ltd, and their sole director, alleging unlawful advertising of medicinal cannabi…
Read the full Australia TGA brief →
Get every Australia TGA brief delivered the day it lands
From $149/month
Cresthaven Analytics monitors Therapeutic Goods Administration continuously, applying institutional materiality scoring to every release. Subscribers receive structured briefs via email, portal, and (Professional tier and above) real-time alerts.
View all tiers →